Human T‐cell leukemia virus (HTLV‐I) p24 antibody in New York City blood product recipients
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Human T‐cell leukemia virus (HTLV‐I) is known to be associated with certain hematologic malignancies, and a related virus, HTLV‐III/LAV, might be the cause of AIDS. Some persons with AIDS have had evidence of HTLV‐I infection. Unrelated to these findings, it has been suggested that HTLV‐I is transmitted via blood products. We therefore evaluated the serologic status to the HTLV‐I core antigen p24 of 48 persons with hemophilia (Hem A) receiving factor concentrate therapy (a group at risk for AIDS), 49 persons with β‐thalassemia major (Thal) receiving frozen packed red blood cells therapy (FPRC), 26 patients with sickle cell anemia (SCA) receiving FPRC, and 18 persons not receiving any blood products. All participants were clinically well; only one had a risk factor other than hemophilia for AIDS, and all were from New York City, an area with a high incidence of AIDS. No Hem A or nontransfused persons had serum antibody to HTLV core p24 antigen; three with Thal and one with SCA were antibody‐positive. These results were confirmed by both radioimmunoprecipitation and Western blot techniques. Positive serology did not correlate with any immune findings or quantity of blood products used. These data support that HTLV‐I is preferentially transmitted through cellular blood products and that it is an infection for which cellular blood product recipients in at least some areas of the United States are at risk. Concentrate products appear free of transmission risk relative to cellular blood products, but we cannot be certain that this safety is absolute. The public health implications of blood product transmission of HTLV‐I merit active, long‐term investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yamamoto, N., Okada, M., Koyanagi, Y., Kannagi, M., & Hinuma, Y. (1982) · Science · doi:10.1126/science.6980467 · Cited by 398
Cited by
High Rate of HTLV-II Infection in Seropositive IV Drug Abusers in New Orleans
Lee, H., Swanson, P., Shorty, V. S., Zack, J. A., Rosenblatt, J. D., & Chen, I. S. Y. (1989) · Science · doi:10.1126/science.2655084 · Cited by 424
Seroprevalence and Epidemiological Correlates of HTLV-I Infection in U.S. Blood Donors
Williams, A. E., Fang, C. T., Slamon, D. J., Poiesz, B. J., Sandler, S. G., Darr, W. F., Shulman, G., McGowan, E. I., Douglas, D. K., Bowman, R. J., et al. (1988) · Science · doi:10.1126/science.2896386 · Cited by 265
Manns, A., & Blattner, W. A. (1991) · Transfusion · doi:10.1046/j.1537-2995.1991.31191096189.x · Cited by 174
Coskun, A. K., & Sutton, R. E. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.4150-4158.2005 · Cited by 48
HTLV-1 infection of myeloid cells: from transmission to immune alterations
Rocamonde, B., Carcone, A., Mahieux, R., & Dutartre, H. (2019) · Retrovirology · doi:10.1186/s12977-019-0506-x · Cited by 31
Metadata
- Authors
- Jason, J. M., McDougal, J. S., Cabradilla, C., Kalyanaraman, V. S., & Evatt, B. L.
- Venue
- American Journal of Hematology
- Publisher
- Wiley
- Published
- 1985-01
- Volume
- 20
- Issue
- 2
- Pages
- 129-137
- ISSN
- 0361-8609 (ISSN-L)
- 1096-8652
- OpenAlex
- W2143704583
- Cited by
- 46
- References
- 1
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.